Eolas Medical has announced the close of its £9 million Series A round led by Acton Capital, with investment from Whiterock Capital, Portfolio Ventures, ScaleX Investments, Kindred Capital, Samaipata, and Ascension, whose renewed commitment reflects strong confidence in the company’s unique approach to reinventing how clinicians access medical knowledge.
Every day, over 50 million healthcare professionals make 2 billion medical decisions across the globe, yet clinicians still struggle to find context specific medical knowledge at the point of care.
Hospitals and healthcare systems rely on thousands of guidelines, protocols, and policies. These vary between institutions. The information is fragmented, often buried across PDFs, shared drives, and intranets. The consequences are delayed decisions, inconsistent care, preventable errors, inefficiency, staff frustration, and unnecessary cost.
Eolas Medical exists to solve this problem. Its mission is clear: Make sure every healthcare professional can instantly and easily access the medical knowledge they need, exactly when they need it.
Eolas Medical already supports clinicians in more than 500 healthcare sites globally including in over 85% of acute NHS hospitals across the UK, over 40% of doctors in Ireland, and across major US health systems such as Stanford Healthcare and Massachusetts General Hospital. According to clinicians, the platform reduces up to 90% time spent searching for clinical knowledge, dramatically improving safety, efficiency, and adherence to best practices.
The Series A funding enables Eolas Medical to accelerate the development and global scale of its AI powered clinical knowledge platform. This investment will allow the company to expand its presence across the US, Europe and global healthcare systems and scale commercial, engineering, and clinical teams to meet international demand.
